[EXPERIENCE OF APPLICATION OF THE GENE INDUCTOR OF VASCULAR ENDOTHELIUM GROWTH FACTOR IN TREATMENT OF PATIENTS, SUFFERING ATHEROSCLEROTIC ISCHEMIA OF THE LOWER EXTREMITIES TISSUES].
The results of examination of patients, suffering chronic ischemia of the lower extremities (LE) stages IIB - III (according to Fontaine), in whom preparation Neovasculgen was used in complex of medicinal therapy, were presented. In terms of follow-up before 12 months the distance, which the patients passed before the pain occurrence, have enhanced by 92.2%, and the ankle-brachial index--by 30.9%. Complications while application of the preparation were absent. Due to the treatment conducted there were LE saved and the patients' quality of life improved.